Introducing π-HelixNovo for practical large-scale de novo peptide sequencing
Briefings in Bioinformatics · 22.01.2024 · 25 (2)
DOI: 10.1093/bib/bbae021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, online erschienen am 10.02.2024. Verfasst von Tingpeng Yang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Peng Cheng Laboratory, Shenzhen, 518055, China. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Sequence Analysis, Protein. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Chinese Ministry of Technology to Peng Cheng Laboratory, National Key Research and Development Program of China, Research and Development Program of Guangzhou Laboratory.
Abstract (Originalsprache)
De novo peptide sequencing is a promising approach for novel peptide discovery, highlighting the performance improvements for the state-of-the-art models. The quality of mass spectra often varies due to unexpected missing of certain ions, presenting a significant challenge in de novo peptide sequencing. Here, we use a novel concept of complementary spectra to enhance ion information of the experimental spectrum and demonstrate it through conceptual and practical analyses. Afterward, we design suitable encoders to encode the experimental spectrum and the corresponding complementary spectrum and propose a de novo sequencing model $\pi$-HelixNovo based on the Transformer architecture. We first demonstrated that $\pi$-HelixNovo outperforms other state-of-the-art models using a series of comparative experiments. Then, we utilized $\pi$-HelixNovo to de novo gut metaproteome peptides for the first time. The results show $\pi$-HelixNovo increases the identification coverage and accuracy of gut metaproteome and enhances the taxonomic resolution of gut metaproteome. We finally trained a powerful $\pi$-HelixNovo utilizing a larger training dataset, and as expected, $\pi$-HelixNovo achieves unprecedented performance, even for peptide-spectrum matches with never-before-seen peptide sequences. We also use the powerful $\pi$-HelixNovo to identify antibody peptides and multi-enzyme cleavage peptides, and $\pi$-HelixNovo is highly robust in these applications. Our results demonstrate the effectivity of the complementary spectrum and take a significant step forward in de novo peptide sequencing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Peng Cheng Laboratory, Shenzhen, 518055, China.
- Tsinghua Shenzhen International Graduate School, Shenzhen, 518055, China.
- State Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing, 102206, China.
- School of Life Sciences, Tsinghua University, Beijing 100084, China.
- Research Unit of Proteomics Driven Cancer Precision Medicine, Chinese Academy of Medical Sciences, Beijing 102206, China.
Förderung
- Chinese Ministry of Technology to Peng Cheng Laboratory
- National Key Research and Development Program of China
- Research and Development Program of Guangzhou Laboratory
- National Natural Science Foundation of China
- CAMS Innovation Fund for Medical Sciences
Zitieren
APA
Yang, T., Ling, T., Sun, B., Liang, Z., Xu, F., Huang, X., Xie, L., He, Y., Li, L., He, F., Wang, Y., & Chang, C. (2024). Introducing π-HelixNovo for practical large-scale de novo peptide sequencing. Briefings in Bioinformatics, 25(2). https://doi.org/10.1093/bib/bbae021
Vancouver
Yang T, Ling T, Sun B, Liang Z, Xu F, Huang X, et al. Introducing π-HelixNovo for practical large-scale de novo peptide sequencing. Briefings in Bioinformatics. 2024;25(2). doi:10.1093/bib/bbae021
BibTeX
@article{Yang2024,
author = {Yang, Tingpeng and Ling, Tianze and Sun, Boyan and Liang, Zhendong and Xu, Fan and Huang, Xiansong and Xie, Linhai and He, Yonghong and Li, Leyuan and He, Fuchu and Wang, Yu and Chang, Cheng},
title = {Introducing π-HelixNovo for practical large-scale de novo peptide sequencing},
journal = {Briefings in Bioinformatics},
year = {2024},
volume = {25},
number = {2},
doi = {10.1093/bib/bbae021}
}
EUVIMED